REGULATORY AGENCY ACTION
BUREAU OF PERSONNEL
SERVICES
Chief- Jean Orr
(916) 920-6311
The Bureau of Personnel Services
was established within the Department
of Consumer Affairs (DCA) to regulate
those businesses which secure employment or engagements for others for a
fee. The Bureau regulates both employment agencies and nurses' registries.
Businesses which place applicants in
temporary positions or positions which
command annual gross salaries in excess
of $25,000 are exempt from Bureau regulation; similarly, employer-retained agencies are also exempt from Bureau oversight.
The Bureau's primary objective is to
limit abuses among those firms which
place individuals in a variety of employment positions. It prepares and administers a licensing examination and issues
several types of licenses upon fulfillment
of the Bureau's requirements. Approximately 900 agencies are now licensed by
the Bureau.
The Bureau is assisted by an Advisory
Board created by the Employment Agency
Act. This seven-member Board consists
of three representatives from the employment agency industry and four public
members. All members are appointed
for a term of four years. As of this
writing, seats for one public and two
industry members remain vacant.

MAJOR PROJECTS:
Chief Orr Announces Retirement.
Bureau Chief Jean Orr has announced
her retirement effective June 30, 1989.
In addition to being the only Bureau
Chief to come from within the personnel
services industry, Chief Orr's service
since her appointment six years ago
makes her the longest-serving Chief the
Bureau has had. Chief Orr began her
tenure with the Bureau in July 1983 as
an appointee of Governor Deukmejian.
She continues to voice her opposition to
the ongoing dismantling of the Bureau,
and states that she is proud of her staffs
accomplishments. Specifically, she believes the Bureau's efforts in securing
the closure of several large illegitimate
employment agencies has protected many
California consumers.
LEGISLATION:
The following is a status update on
bills discussed in detail in CRLR Vol. 9,
No. 2 (Spring 1989) at page 70:
AB 2113 (Johnson), as amended May
17, is entitled the "Personnel and Employment Agency Services Act." It would
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repeal the entire Employment Agency
Act of the Business and Professions
Code, including all provisions which provide for the Bureau's funding, examining,
licensing, and regulatory functions. The
bill would also reenact certain provisions
of the Act as part of the Civil Code so
that the contents of employment agency
contracts, advertising, and fees of such
agencies would be regulated by statute,
not by the Bureau.
Specifically, AB 2113 proposes to:
(l) delete licensing and regulation by the
Bureau; (2) provide for a three-day cancellation period during which a job seeker may cancel a contract with an employment agency; (3) eliminate the bond
requirement for certain employment agencies; (4) require the filing of the bond
with the Secretary of State rather than
with the Bureau; (5) revise standards of
conduct for employment agencies; (6)
make specified violations of those provisions also a violation of unfair trade
practices law, as specified; (7) make certain contracts entered into by reason of
fraud or misrepresentation void and unenforceable; and (8) provide for a civil
penalty and a cause of action for damages by any person injured by reason of
a violation of those provisions. Additionally, the DCA must submit to the legislature a preliminary report regarding the
implementation of this bill by March
31, 1990; and a final report by June 30,
1991.
According to DCA staff counsel Jay
DeFuria, the Bureau's licensure requirement helps promote competence, but
most problems in the personnel services
industry relate to fraud, not incompetence. He states that the Bureau, with
its revenue base limited by the partial
industry deregulation under AB 2929,
cannot effectively protect consumers from
fraud. AB 2929 (Chapter 912, Statutes
of 1986) removed employer-retained agencies from the Bureau's oversight as of
July l, 1987. The Bureau suffered a 60%
decline in its funding as a result of this
decrease in the number of its licensees.
(For more information on the effects of
AB 2929, see CRLR Vol. 9, No. l (Winter 1989) p. 59 and Vol. 8, No. 4 (Fall
1988) p. 68.)
According to DeFuria, AB 2113
would provide enforcement remedies
which will protect consumers from fraud,
and may be further amended to include
enhanced recovery of costs for the Attorney General and for local district attorneys who bring actions against employment agencies under the new Act. He
says the substantive law requirements
for employment agencies will remain

mostly unchanged.
AB 2113 has survived a policy analysis by the Assembly Governmental Efficiency and Consumer Protection Committee and is pending in the Assembly
Ways and Means Committee at this writing. Bureau Chief Orr is dissatisfied
with AB 2113, as amended. She believes
the Attorney General and local district
attorneys do not want the added workload of conducting initial investigations
of consumer fraud complaints. She believes many consumers, particularly
minorities, will be victims of defrauding
specialists, and will have no realistic
means of redress.
AB 2469 (Johnston) would continue
the present deregulation of employerpaid agencies which occurred under AB
2929 beyond the January l, 1991 sunset
date. This bill passed the Assembly on
June 7 and is awaiting committee assignment in the Senate at this writing.
SB 1673 (Montoya), which would
add an applicant's complaint history to
the Bureau's criteria for evaluating possible restrictions on an applicant's license,
is a two-year bill pending in the Senate
Business and Professions Committee.
FUTURE MEETINGS:
To be announced.

BOARD OF PHARMACY
Executive Officer: Lorie G. Rice
(916) 445-5014
The Board of Pharmacy grants licenses and permits to pharmacists, pharmacies, drug manufacturers, wholesalers
and sellers of hypodermic needles. It regulates all sales of dangerous drugs, controlled substances and poisons. To enforce
its regulations, the Board employs fulltime inspectors who investigate accusations and complaints received by the
Board. Investigations may be conducted
openly or covertly as the situation demands.
The Board conducts fact-finding and
disciplinary hearings and is authorized
by law to suspend or revoke licenses or
permits for a variety of reasons, including professional misconduct and any acts
substantially related to the practice of
pharmacy.
The Board consists of ten members,
three of whom are public. The remaining
members are pharmacists, five of whom
must be active practitioners. All are appointed for four-year terms.
MAJOR PROJECTS:
Examination Changes. On April IO,
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REGULATORY AGENCY ACTION
the Office of Administrative Law (OAL)
disapproved the Board's proposed amendments to section 1724, Chapter 17, Title
16 of the California Code of Regulations
(CCR), which would have revised the
pharmacists' examination format. (See
CRLR Vol. 9, No. 2 (Spring 1989) p. 70
and Vol. 9, No. I (Winter 1989) p. 66
for background information.) OAL's decision to disapprove the proposed regulation cited problems in the areas of
necessity and clarity. The proposed amendments, with supporting changes in the
rulemaking file, were resubmitted to OAL
and approved on May 18.
Regulatory Hearings Held. The Board
conducted hearings in May to receive
comment on three proposed regulatory
changes. The first proposal would amend
section 1707.1, Chapter 17, Title 16 of
the CCR. The amended regulation would
require pharmacists to orally consult with
the patient whenever a prescription drug
is dispensed for the first time. The amendment would also require that the consultation include at least directions for use,
precautions, and relevant warnings. After
the hearing, the Board slightly modified
the language of the proposed amendment, and approved the change subject
to another comment period which ended
on July 17.
The second proposal would amend
section 1717(c), Chapter 17, Title 16 of
the CCR. (See CRLR Vol. 9, No. 2
(Spring 1989) pp. 70-71 for background
information.) The proposed regulation
would authorize an unlicensed person,
under the supervision of the pharmacist,
to perform any task except the following:
receiving new verbal prescription orders;
consulting with a patient, prescriber, or
other health professional regarding a prescription or medical information; evaluating prescriptions; interpreting patient
records; and verifying prescriptions before dispensing. By identifying the functions that only the licensed pharmacist
may perform, the regulation would permit
the increased use of non-licensed personnel for more routine tasks within pharmacies. The Board also approved of these
changes subject to minor modifications,
which were released for another public
comment period ending July 17.
The third regulatory proposal adopted at the May meeting would add section
1710 to Chapter 17, Title 16 of the
CCR. This section would define an inpatient hospital pharmacy as a hospital
pharmacy predominantly furnishing drugs
to outpatients, employees, and walk-in
customers, provided that the walk-in
customers are less than I% of the pharmacy's sales of drugs. A definition of
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this term is required by the language of
section 4080.5 of the Business and Professions Code, which significantly restricts prescriber ownership of pharmacies, except for hospital pharmacies.
English Proficiency Examination.
The Board was scheduled to hold a July
25 hearing in Sacramento to receive comments on a proposed amendment to section 1719, Chapter 17, Title 16 of the
CCR. The existing regulation requires
an examination candidate to have graduated from an accredited school of pharmacy and to have gained a minimum of
1,000 hours of intern experience prior to
applying for the examination. The proposed amendment would additionally require all candidates to take and pass,
prior to applying for the examination,
the Test of Spoken English administered
by the Educational Testing Service.
Corresponding Responsibility. At its
March meeting, the Board approved guidelines from the Committee on Corresponding Liability, which studied implementation of section 1761, Chapter 17, Title
16 of the CCR. Section 1761 imposes
disciplinary liability on a pharmacist who
dispenses a controlled substance if the
pharmacist knows or has reason to know
that the prescription was not issued for
a legitimate medical purpose. This corresponding liability provision resulted in
questions from pharmacists about how
to evaluate suspicious prescriptions for
controlled substances.
The guidelines offer a list of factors
relating to the patient, prescriber, and
the therapeutic appropriateness of the
prescription to be considered in determining whether a controlled substance
prescription is questionable.
Scope of Practice. The Ad Hoc Committee on Scope of Practice was scheduled to meet on July 12 in Sacramento.
(See CRLR Vol. 9, No. 2 (Spring 1989)
p. 71 and Vol. 9, No. I (Winter 1989) p.
61 for background information.) Items
scheduled for discussion included regulatory action pertaining to Schedule II
prescriptions and pain management, furnishing medication and supplies to parenteral patients, and approval of consultation areas in pharmacies.
LEGISLATION:
AB 1177 (Kelley) would make technical changes in section 4008 of the
Business and Professions Code relating
to the Board of Pharmacy. This is now
a two-year bill.
The following is a status update on
bills discussed in detail in CRLR Vol. 9,
No. 2 (Spring 1989) at page 71:
AB 102 (Fi/ante), which would amend
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the existing law which created a Legislative Task Force on Medication Misuses
to design a model medication program
and a brochure, is pending in the Senate
Health and Human Services Committee.
AB 229 (Polanco), which would restrict the distribution, possession, and
use of hypodermic needles and syringes,
is still pending in the Senate Business
and Professions Committee.
AB 1006 (Isenberg), which would
require health maintenance organizations
to allow non-contracting pharmacies to
provide services to beneficiaries and to
be paid an amount equal to the contract
payment, is pending in the Assembly
Finance and Insurance Committee.
AB 1397 (Fi/ante), which would require pharmacist consultation when an
initial prescription is filled or when a
pharmacist deems that a consultation is
warranted, is pending in the Assembly
Health Committee.
AB 1591 (Condit), which would
amend section 1056 of the Health and
Safety Code to include anabolic steroids
on the list of controlled prescription
substances, is pending in the Senate
Judiciary Committee.
AB 1729 (Chandler), which would
increase the penalties for subversion of
a licensing examination, is pending in
the Assembly Ways and Means Committee.
AB 1986 (Ferguson), which would
create felony criminal and civil penalties
for prescribing controlled substances to
minors without the written consent of
parents or guardians, is currently pending in the Assembly Judiciary Committee.
FUTURE MEETINGS:
To be announced.

POLYGRAPH EXAMINERS
BOARD
Executive Officer: Dia Goode
(916) 739-3855
The Polygraph Examiners Board
operates within the Department of Consumer Affairs. The Board has authority
to issue new licenses and to regulate the
activities of an estimated 655 examiners
currently licensed in California under
Business and Professions Code section
9300 et seq. The Board has no jurisdiction over federally-employed polygraph
examiners and very limited jurisdiction
in the non-criminal arena.
The Polygraph Examiners Board consists of two industry representatives and
three public members, all appointed to
four-year terms. The Board has a sunset
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